News

Medical Dialogues2h
Roche receives USFDA approval for VENTANA MET (SP44) RxDx Assay as companion diagnostic in non-small cell lung cancer
Basel: Roche has announced that the FDA has approved the VENTANA MET (SP44) RxDx Assay, the first companion diagnostic ...
Medical Dialogues4h
Bristol Myers Squibb bags European Commission approval for Opdivo combo in lung cancer treatment
Princeton: Bristol Myers Squibb has announced that the European Commission (EC) has approved the perioperative regimen of ...
Sportschosun on MSN6h
Smoking for more than 30 years and 20 packs, 54 times higher risk of small cell lung cancer...Genetic factors are low
A study found that those who smoked for more than 30 years and 20 packs per day (a pack per day × 20 years) have a 54 times ...
CURE17h
Tagrisso Therapy Elicits Wave of New Therapeutic Approaches in NSCLC
Dr. Suresh Ramalingam discussed how the LAURA findings support the role of Tagrisso as a backbone therapy across multiple ...